| Literature DB >> 34765492 |
Matthew O Wiens1,2,3, Niranjan Kissoon1,4, Liisa Holsti5.
Abstract
OBJECTIVE: The objective of this narrative review is to outline the current epidemiology and interventional research within the context of sepsis recovery, and to provide a summary of key priorities for future work in this area.Entities:
Keywords: Sepsis; infection; low- and middle-income country (LMIC); pediatrics; post-discharge mortality
Year: 2021 PMID: 34765492 PMCID: PMC8578768 DOI: 10.21037/tp-20-390
Source DB: PubMed Journal: Transl Pediatr ISSN: 2224-4336
Randomized controlled trials of pharmacologic interventions during the post-discharge period
| Study | Country/countries | Population | Intervention | Outcome | Effectiveness demonstrated | Outcome rate/observed reduction |
|---|---|---|---|---|---|---|
| ( | Kenya | 1,778 malnourished children discharged following infection | Daily co-trimoxazole ×6 months | Mortality | No | Approx. 15% at 1 year in both groups |
| ( | Uganda/Malawi | 3,986 children with severe anemia discharged from hospital | Multi-nutrient intervention with or without co-trimoxazole ×3 months | Mortality | No | Approx. 8% at 6 months in all groups |
| ( | Kenya | 1,400 children <5 discharged from hospital | Azithromycin ×5 days | Mortality or readmission | Ongoing | NA |
| ( | Malawi | 1,414 discharged and severe malarial anemia | Intermittent preventative therapy with artemether lumefantrine ×2 months | Mortality or readmission | Yes, but limited to first 3 months | Adjusted protective efficacy: 31% (95% CI: 5–50) |
| ( | Kenya/Uganda | 1,049 discharged and severe malarial anemia | Intermittent preventative therapy with dihydroartemisinin-piperaquine ×10 weeks | Mortality or readmission | Yes, but limited to first 3 months | HR: 0.65 (95% CI: 0.54–0.78) |